Dendritic cell activation enhances anti-PD-1 mediated immunotherapy against glioblastoma

INTRODUCTION: The glioblastoma (GBM) immune microenvironment is highly suppressive as it targets and hinders multiple components of the immune system. Checkpoint blockade (CB) is being evaluated for GBM patients. However, biomarker analyses suggest that CB monotherapy may be effective only in a smal...

Full description

Saved in:
Bibliographic Details
Published in:Oncotarget
Main Authors: Garzon-Muvdi, Tomas, Theodros, Debebe, Luksik, Andrew S., Maxwell, Russell, Kim, Eileen, Jackson, Christopher M., Belcaid, Zineb, Ganguly, Sudipto, Tyler, Betty, Brem, Henry, Pardoll, Drew M., Lim, Michael
Format: Artigo
Language:Inglês
Published: Impact Journals LLC 2018
Subjects:
Research Paper
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5945499/
https://ncbi.nlm.nih.gov/pubmed/29755681
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.25061
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items